Research reveals that senescent cells show upregulation of pro-apoptotic initiators PUMA and BIM while anti-apoptotic guardian BCL-2 is reduced, suggesting these cells are ready to undergo apoptosis but the execution is restrained by the FOXO4-p53 interaction
This is desirable for wound healing but theoretically problematic for patients with active malignancies or a history of angiogenesis-dependent tumors
Your body already produces thousands of them naturally
Reactions to Watch For While rare, some individuals may experience adverse reactions to semaglutide
Any findings referenced are derived from experimental models and controlled research settings and should not be interpreted as therapeutic or clinical outcomes
Li N, Liu R-J, Dwyer JM, Banasr M, Lee B, Son H, et al